1. PARP-1 Inhibitors in Oncology The Discovery and Development of CEP-9722, an Orally Active Prodrug for the Treatment of Cancer 2. Rationale for PARP-1 Inhibitors in Oncology…

1. Presentation for The Structure Based DrugDesign ConferenceCambridge. MA 2009 2. Track Record Domainex’s contribution to client drug discovery programmes has directly…

Slide 1PhysChem Forum, 29 Nov 2006, Newhouse 1 Memories and the future: From experimental to in silico physical chemistry Han van de Waterbeemd AstraZeneca, DMPK Alderley…

Slide 1 INFSO-RI-508833 Enabling Grids for E-sciencE www.eu-egee.org Using Grid Computing to Accelerate Structure-Based Design Against Influenza A Neuraminidases Hurng-Chun…

Slide 1 Chemical Data and Computer-Aided Drug Discovery Mike Gilson School of Pharmacy [email protected] 2-0622 Slide 2 Outline Overview of drug discovery Structure-based…